(S (S (VP (VBG Classifying) (NP (NNS chemicals)) (PP (VBG according) (PP (TO to) (NP (NP (NP (JJ putative) (NNS modes)) (PP (IN of) (NP (NN action)))) (PRN (-LRB- -LRB-) (NP (NNP MOAs)) (-RRB- -RRB-))))))) (VP (VBZ is) (PP (IN of) (NP (NN paramount) (NN importance))) (PP (IN in) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (NN risk) (NN assessment)))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (JJ current) (NNS methods)) (VP (VBP are) (ADVP (RB only)) (ADJP (JJ able) (S (VP (TO to) (VP (VB handle) (NP (NP (DT a) (ADJP (RB very) (JJ small)) (NN proportion)) (PP (IN of) (NP (DT the) (VBG existing) (NNS chemicals))))))))) (. .))
(S (NP (PRP We)) (VP (VBP address) (NP (DT this) (NN issue)) (PP (IN by) (S (VP (VBG proposing) (NP (NP (DT an) (JJ integrative) (NN deep) (NN learning) (NN architecture)) (SBAR (WHNP (WDT that)) (S (VP (VBZ learns) (NP (DT a) (JJ joint) (NN representation)) (PP (IN from) (NP (NP (NP (JJ molecular) (NNS structures)) (PP (IN of) (NP (NNS drugs)))) (CC and) (NP (NP (PRP$ their) (NNS effects)) (PP (IN on) (NP (JJ human) (NNS cells)))))))))))))) (. .))
(S (NP (NP (PRP$ Our) (NN choice)) (PP (IN of) (NP (NN architecture)))) (VP (VBZ is) (VP (VBN motivated) (PP (IN by) (NP (NP (DT the) (JJ significant) (NN influence)) (PP (IN of) (NP (NP (DT a) (NN drug) (POS 's)) (NN chemical) (NN structure))) (PP (IN on) (NP (PRP$ its) (NNP MOA))))))) (. .))
(S (NP (PRP We)) (VP (VBP improve) (PP (IN on) (NP (NP (DT the) (JJ strong) (NN ability)) (PP (IN of) (NP (NP (DT a) (JJ unimodal) (NN architecture)) (PRN (-LRB- -LRB-) (NP (NP (NNP F1) (NN score)) (PP (IN of) (NP (CD 0.803)))) (-RRB- -RRB-)))) (S (VP (TO to) (VP (VB classify) (NP (NNS drugs)) (PP (IN by) (NP (NP (PRP$ their) (NN toxic) (NNP MOAs)) (PRN (-LRB- -LRB-) (NP (NNP Verhaar) (NN scheme)) (-RRB- -RRB-))))))))) (PP (IN through) (S (VP (VBG adding) (NP (NP (DT another) (NN learning) (NN stream)) (SBAR (WHNP (WDT that)) (S (VP (VBZ processes) (NP (NP (JJ transcriptional) (NNS responses)) (PP (IN of) (NP (NP (JJ human) (NNS cells)) (VP (VBN affected) (PP (IN by) (NP (NNS drugs))))))))))))))) (. .))
(S (S (NP (PRP$ Our) (JJ integrative) (NN model)) (VP (VBZ achieves) (NP (DT an) (ADJP (RB even) (JJR higher)) (NN classification) (NN performance)) (PP (IN on) (NP (DT the) (NNP LINCS) (NNP L1000) (SYM dataset))))) (: -) (S (NP (DT the) (NN error)) (VP (VBZ is) (VP (VBN reduced) (PP (IN by) (NP (CD 4.6) (NN %)))))) (. .))
(S (NP (PRP We)) (VP (VBP believe) (SBAR (IN that) (S (NP (PRP$ our) (NN method)) (VP (MD can) (VP (VB be) (VP (VP (VBN used) (S (VP (TO to) (VP (VB extend) (NP (DT the) (JJ current) (NNP Verhaar) (NN scheme)))))) (CC and) (VP (VB constitute) (NP (NP (DT a) (NN basis)) (PP (IN for) (NP (JJ fast) (NX (NX (NN drug) (NN validation)) (CC and) (NX (NN risk) (NN assessment))))))))))))) (. .))
